Jupiter Neurosciences, Inc.
JUNS
$0.89
-$0.05-4.81%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/23/2026
-
ACCESS Newswire
12/23/2025
-
Globe Newswire
12/22/2025
-
TipRanks Financial Blog
12/3/2025
-
GuruFocus
12/3/2025
-
The Fly
12/3/2025
-
GuruFocus
12/3/2025
-
Globe Newswire
12/2/2025
-
Newsfile Corp. - News Releases
11/5/2025
-
TipRanks Financial Blog
11/5/2025
-
The Fly
11/5/2025
-
GuruFocus
11/5/2025
-
Globe Newswire
10/27/2025
-
GuruFocus
10/27/2025
-
The Fly
10/27/2025
-
Globe Newswire
9/15/2025
-
The Fly
9/15/2025
-
Globe Newswire
8/26/2025
-
GuruFocus
8/26/2025
-
TipRanks Financial Blog
8/26/2025
-
The Fly
8/26/2025
-
Globe Newswire
8/19/2025
-
The Fly
8/19/2025
-
Globe Newswire
8/11/2025
-
The Fly
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
(est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
561 406 6154
Address
1001 North US Highway 1
Jupiter, FL 33477
Jupiter, FL 33477
Country
Year Founded
Business Description
Sector
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops...
more